By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher announced late on Tuesday that it has extended its offer to buy Beckman Coulter to expire at midnight EDT April 27.

The offer had been set to expire at midnight EDT today. All other terms and conditions of Danaher's $6.8 billion bid for Beckman Coulter are unchanged.

The deal is expected to close during the second quarter, Danaher said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.